The challenge of overcoming resistance mechanisms in advanced non-small cell lung cancer
The challenge of overcoming resistance mechanisms in advanced non-small cell lung cancer (NSCLC) has been a persistent focus in thoracic oncology. Osimertinib, a third-generation epidermal...